Q1 2026 Cencora Inc Earnings Call Transcript
Key Points
- Cencora Inc (COR) reported a 12% growth in adjusted operating income and a 9% increase in adjusted diluted EPS for the first quarter of fiscal 2026.
- The acquisition of OneOncology is expected to significantly contribute to Cencora's growth, with the company raising its fiscal 2026 guidance to reflect an 11.5% to 13.5% year-over-year adjusted operating income growth.
- The US Healthcare Solutions segment showed strong performance, with a 21% increase in operating income, driven by the acquisition of Retina Consultants of America and continued specialty growth.
- Cencora's investments in MSOs (Management Services Organizations) are expected to unlock new opportunities and enhance solutions for providers and biopharma, particularly in clinical research and revenue cycle management.
- The company is leveraging technology and advanced analytics to differentiate its solutions in the market, capitalizing on strong specialty pharmaceutical utilization trends.
- Cencora faced a headwind from the loss of an oncology customer acquired by a competitor, impacting revenue growth in the US Healthcare Solutions segment.
- The International Healthcare Solutions segment experienced a 14% decline in operating income due to timing issues with manufacturer price adjustments in a developing market country.
- Net interest expense increased significantly to $72 million, primarily due to debt raised for the RCA acquisition, with expectations of further increases due to the OneOncology acquisition.
- The company reported negative adjusted free cash flow of $2.4 billion for the quarter, attributed to seasonal working capital needs.
- Cencora has paused share repurchases to prioritize debt pay-down following the OneOncology acquisition, which may impact shareholder returns in the short term.
Hello everyone and thank you for joining the Cencora fiscal 2026 first quarter results call. My name is Lucy and I'll be coordinating your call today. (Operator Instructions)
It is now my pleasure to hand over to your host, Bennett Murphy, Senior Vice President of Investor Relations and Enterprise Productivity to begin. Please go ahead.
Good morning. Good afternoon. Thank you all for joining us for this conference call to discuss Cencora's fiscal 2026 first quarter results. I am Bennett Murphy, Senior Vice President, Investment Relations and Enterprise Productivity. Joining me today are Bob Mauch, President and CEO; and Jim Cleary, Executive Vice President and CFO.
On today's call, we will be discussing non-GAAP financial measures. Reconciliations of these measures to GAAP are provided in today's press release, which is available on our website at investor.cencora.com. We've also posted a slide presentation to accompany today's press release on our investor website.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
